Together Pharma Income Statement

Financials in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	109.22	96.05	91.01	31.23	12.03	11.22
Revenue Growth (YoY)	13.90%	5.55%	191.42%	159.67%	7.16%	-
Cost of Revenue	92.1	78.54	56.38	37.12	14.2	-17.06
Gross Profit	17.12	17.51	34.62	-5.89	-2.17	28.29
Selling, General & Admin	16.74	14.24	12.53	11.61	9.55	11.29
Other Operating Expenses	-	-	-	2.27	-1.71	0.37
Operating Expenses	16.74	14.24	12.53	13.88	9.28	11.66
Operating Income	0.38	3.27	22.09	-19.77	-11.46	16.63
Interest Expense	-8.24	-9.47	-19.59	-17.2	-14.8	-11.85
Interest & Investment Income	-	4.32	-	-	10.88	8.89
Earnings From Equity Investments	-	-	-0.25	-0	-	-
Currency Exchange Gain (Loss)	0.57	0.57	0.54	1.76	-0.41	-1.44
Other Non Operating Income (Expenses)	-0.9	-0.9	-1.25	-1.11	0.01	1.94
EBT Excluding Unusual Items	-8.2	-2.21	1.54	-36.33	-15.78	14.16
Pretax Income	-8.2	-2.21	1.54	-36.33	-15.12	14.16
Income Tax Expense	-0.98	-0.59	4.07	-0.85	-	-1.31
Earnings From Continuing Operations	-7.22	-1.62	-2.53	-35.48	-15.12	15.47
Net Income to Company	-7.22	-1.62	-2.53	-35.48	-15.12	15.47
Minority Interest in Earnings	0.66	0.45	-1.78	1.96	1.34	-8.32
Net Income	-6.56	-1.17	-4.32	-33.52	-13.78	7.15
Net Income to Common	-6.56	-1.17	-4.32	-33.52	-13.78	7.15
Shares Outstanding (Basic)	14	12	9	8	7	6
Shares Outstanding (Diluted)	14	12	9	8	7	6
Shares Change (YoY)	41.07%	41.39%	7.81%	18.96%	18.76%	14.93%
EPS (Basic)	-0.47	-0.09	-0.49	-4.15	-2.05	1.27
EPS (Diluted)	-0.51	-0.09	-0.49	-4.18	-2.23	1.22
Free Cash Flow	9.21	1.37	13.97	-14.07	-20.17	-23.46
Free Cash Flow Per Share	0.66	0.11	1.59	-1.73	-2.94	-4.07
Gross Margin	15.67%	18.23%	38.04%	-18.86%	-18.07%	252.03%
Operating Margin	0.34%	3.41%	24.28%	-63.30%	-95.27%	148.18%
Profit Margin	-6.01%	-1.22%	-4.74%	-107.35%	-114.55%	63.73%
Free Cash Flow Margin	8.44%	1.43%	15.35%	-45.04%	-167.75%	-208.99%
EBITDA	6.16	8.93	27.62	-14.37	-6.14	20.56
EBITDA Margin	5.64%	9.30%	30.34%	-46.01%	-51.04%	183.15%
D&A For EBITDA	5.78	5.66	5.52	5.4	5.32	3.93
EBIT	0.38	3.27	22.09	-19.77	-11.46	16.63
EBIT Margin	0.34%	3.41%	24.28%	-63.30%	-95.27%	148.18%
Effective Tax Rate	-	-	264.65%	-	-	-
Advertising Expenses	-	0.63	0.57	0.83	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.